News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
335 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21087)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
BioMidwest
Centene Corporation Prices Offering Of Common Stock At $0.001 Per Share
Centene Corporation announced that it has priced its previously announced registered offering of $2.6 billion in shares of common stock, par value $0.001 per share, at a public offering price of $107.50 per share.
May 1, 2018
·
4 min read
Business
Natera Inc. Announces First Quarter 2018 Earnings Conference Call
Natera announced that it will release results for its first quarter ended March 31, 2018, after the market close on May 8, 2018.
May 1, 2018
·
1 min read
Business
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
Medicure Inc. reported its results from operations for the quarter and year ended December 31, 2017.
May 1, 2018
·
28 min read
Business
Brookdale Announces First Quarter 2018 Release and Earnings Call
Brookdale Senior Living Inc. announced that it plans to release its first quarter 2018 financial results after the market closes on Monday, May 7, 2018.
May 1, 2018
·
1 min read
Policy
MacuHealth And Med Op Health Settle Lawsuit
Reiner Rittinghausen (President of Med Op) and Frederic Jouhet (owner and CEO of MacuHealth) met in New York city during Vision Expo East and came to a mutual and satisfactory agreement between their respective groups.
May 1, 2018
·
1 min read
Biotech Bay
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
Avinger, Inc. announced that its next generation Pantheris® Lumivascular atherectomy system with extended nosecone was featured in a live case transmission at Charing Cross Symposium (CX) 2018 held in London, England.
May 1, 2018
·
3 min read
BioMidwest
Exact Sciences to participate in two investor conferences during May 2018
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will be presenting at the following investor conferences during May and invited investors to participate by webcast.
May 1, 2018
·
4 min read
Press Releases
Maravai LifeSciences Expands Top Management Team with Four New Hires
Maravai LifeSciences announced the addition of four senior management executives.
May 1, 2018
·
2 min read
Business
TapImmune to Present at 2018 Disruptive Growth & Healthcare Conference
TapImmune Inc. announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Disruptive Growth & Healthcare Conference, held May 8-9, 2018 at Reed Smith LLP in New York City.
May 1, 2018
·
2 min read
Business
Notice of Cipher Pharmaceuticals Q1 2018 Conference Call & Annual Meeting
Cipher Pharmaceuticals Inc. announced the details of its Q1 2018 financial results conference call and Annual and Special Meeting of shareholders on Thursday, May 10, 2018.
May 1, 2018
·
1 min read
Previous
4 of 34
Next